Effect of NK cell immunotherapy on immune function in patients with hepatic carcinoma: A preliminary clinical study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effect of NK cell immunotherapy on immune function in patients with hepatic carcinoma: A preliminary clinical study

Published:2017-03-29 Issue:5 Volume:18 Page:323-330
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Qin Zilin¹,Chen Jibing²,Zeng Jianying²,Niu Lizhi¹²,Xie Silun³,Wang Xiaohua²,Liang Yingqing²,Wu Zhenyi³,Zhang Mingjie³

Affiliation:

1. School of Medicine, Jinan University, Guangdong Province, Guangzhou, China

2. Fuda Cancer Hospital, Jinan University School of Medicine, Guangzhou Fuda Cancer Institute, Guangzhou, Guangdong, China

3. Hank Bioengineering Co., Ltd., Shenzhen, China

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384047.2017.1310346

Reference39 articles.

1. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

2. Hepatocellular carcinoma: ESMO–ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up

3. Immune checkpoint blockade in hepatocellular carcinoma: Current progress and future directions

4. Present and Future of Allogeneic Natural Killer Cell Therapy

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploiting the immune system in hepatic tumor targeting: Unleashing the potential of drugs, natural products, and nanoparticles;Pathology - Research and Practice;2024-04

2. Advances and considerations in the use of immunotherapies for primary hepato-biliary malignancies;Surgical Oncology;2024-02

3. Biomarkers of minimal residual disease and treatment;Advances in Clinical Chemistry;2024

4. Application of adoptive cell therapy in hepatocellular carcinoma;Immunology;2023-07-12

5. The critical role of serum thymidine kinase 1(STK1) in predicting prognosis for immunotherapy in T4 stage lung squamous cell carcinoma;Heliyon;2023-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3